SHASUN PHARMACEUTICALS LTD. - Outcome of Board Meeting

Shasun Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 08, 2015, has approved the conversion of 71,00,000 convertible warrants into equity shares of the Company, which were issued on May 30, 2014 to M/s. Sequent Scientific Limited, Mumbai, on preferential basis at a price of Rs 110 per share including premium of Rs 108 per share.